common.study.topics.clinical

Midodrine Use in Septic Shock

common.study.values.description

“Midodrine Use in Septic Shock”

The investigators aim to perform a randomized, double-blind, placebo-controlled trial to investigate the efficacy of midodrine in decreasing time to IV vasopressor liberation in patients with septic shock.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Midodrine Hydrochloride

Midodrine Hydrochloride, enteral, 10 or 20 mg

placebo

investigational pharmacy formulated placebo comparator

participant.views.study.view.additional

participant.views.study.view.scientific-title

Midodrine Use for Hypotension Requiring IV Vasopressor Therapy in Early Septic Shock

common.study.values.clinical-trial-id

NCT03706053

participant.views.study.view.id

eVOQMa